Complexity of the Wnt/β-catenin pathway: Searching for an activation model

被引:59
作者
Tortelote, Giovane G. [1 ]
Reis, Renata R. [2 ]
Mendes, Fabio de Almeida [2 ]
Abreu, Jose Garcia [2 ]
机构
[1] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil
关键词
Wnt; beta-catenin; LRP5/6; Axin; Development; Stem cell; Cancer; WNT SIGNALING PATHWAY; RECEPTOR-RELATED PROTEIN-6; PLURIPOTENT STEM-CELLS; MAMMARY ONCOGENE INT-1; TUMOR-SUPPRESSOR APC; CYCLIN D1 GENE; BETA-CATENIN; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; AXIS FORMATION;
D O I
10.1016/j.cellsig.2017.08.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Wnt signaling refers to a conserved signaling pathway, widely studied due to its roles in cellular communication, cell fate decisions, development and cancer. However, the exact mechanism underlying inhibition of the GSK phosphorylation towards beta-catenin and activation of the pathway after biding of Wnt ligand to its cognate receptors at the plasma membrane remains unclear. Wnt target genes are widely spread over several animal phyla. They participate in a plethora of functions during the development of an organism, from axial specification, gastrulation and organogenesis all the way to regeneration and repair in adults. Temporal and spatial oncogenetic re-activation of Wnt signaling almost certainly leads to cancer. Wnt signaling components have been extensively studied as possible targets in anti-cancer therapies. In this review we will discuss one of the most intriguing questions in this field, that is how beta catenin, a major component in this pathway, escapes the destruction complex, gets stabilized in the cytosol and it is translocated to the nucleus where it acts as a co-transcription factor. Four major models have evolved during the past 20 years. We dissected each of them along with current views and future perspectives on this pathway. This review will focus on the molecular mechanisms by which Wnt proteins modulate beta-catenin cytoplasmic levels and the relevance of this pathway for the development and cancer.
引用
收藏
页码:30 / 43
页数:14
相关论文
共 240 条
  • [1] beta-catenin is a target for the ubiquitin-proteasome pathway
    Aberle, H
    Bauer, A
    Stappert, J
    Kispert, A
    Kemler, R
    [J]. EMBO JOURNAL, 1997, 16 (13) : 3797 - 3804
  • [2] β-Catenin-Independent Roles of Wnt/LRP6 Signaling
    Acebron, Sergio P.
    Niehrs, Christof
    [J]. TRENDS IN CELL BIOLOGY, 2016, 26 (12) : 956 - 967
  • [3] Ahmed Y, 2002, DEVELOPMENT, V129, P1751
  • [4] Wnt signaling in planarians: new answers to old questions
    Almuedo-Castillo, Maria
    Sureda-Gomez, Miquel
    Adell, Teresa
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2012, 56 (1-3) : 53 - 65
  • [5] Isoquercitrin Suppresses Colon Cancer Cell Growth in Vitro by Targeting the Wnt/β-Catenin Signaling Pathway
    Amado, Nathalia G.
    Predes, Danilo
    Fonseca, Barbara F.
    Cerqueira, Debora M.
    Reis, Alice H.
    Dudenhoeffer, Ana C.
    Borges, Helena L.
    Mendes, Fabio A.
    Abreu, Jose G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (51) : 35456 - 35467
  • [6] Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway
    Amit, S
    Hatzubai, A
    Birman, Y
    Andersen, JS
    Ben-Shushan, E
    Mann, M
    Ben-Neriah, Y
    Alkalay, I
    [J]. GENES & DEVELOPMENT, 2002, 16 (09) : 1066 - 1076
  • [7] Proximal events in Wnt signal transduction
    Angers, Stephane
    Moon, Randall T.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2009, 10 (07) : 468 - 477
  • [8] [Anonymous], NEW J SCI
  • [9] Foxl1-Expressing Mesenchymal Cells Constitute the Intestinal Stem Cell Niche
    Aoki, Reina
    Shoshkes-Carmel, Michal
    Gao, Nan
    Shin, Soona
    May, Catherine L.
    Goson, Maria L.
    Zahm, Adam M.
    Ray, Michael
    Wiser, Caroline L.
    Wright, Christopher V. E.
    Kaestner, Klaus H.
    [J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2016, 2 (02): : 175 - 188
  • [10] Diversity of LEF/TCF action in development and disease
    Arce, L.
    Yokoyama, N. N.
    Waterman, M. L.
    [J]. ONCOGENE, 2006, 25 (57) : 7492 - 7504